Gut microbiota and treatment-resistant schizophrenia: many questions, fewer answers

Mirko Manchia^{1

2

3}, Alessio Squassina^{4

5}, Federica Tozzi⁶, Athos Antoniades⁶, Bernardo Carpiniello^{1

2}

Affiliations

¹ Department of Medical Sciences and Public Health, Section of Psychiatry, University of Cagliari, Cagliari, 09127, Italy.
² Unit of Clinical Psychiatry, University Hospital Agency of Cagliari, Cagliari, 09127, Italy.
³ Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, B3H 4R2, Canada.
⁴ Department of Biomedical Science, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Monserrato, 09042, Italy.
⁵ Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, B3H 2E2, Canada.
⁶ Research and Development, Stremble Ventures, Limassol, 3095, Cyprus.

Editorial

Mirko Manchia et al. Pharmacogenomics. 2022 Apr.

. 2022 Apr;23(5):277-280.

doi: 10.2217/pgs-2022-0018. Epub 2022 Mar 3.

Mirko Manchia^{1

2

3}, Alessio Squassina^{4

5}, Federica Tozzi⁶, Athos Antoniades⁶, Bernardo Carpiniello^{1

2}

¹ Department of Medical Sciences and Public Health, Section of Psychiatry, University of Cagliari, Cagliari, 09127, Italy.
² Unit of Clinical Psychiatry, University Hospital Agency of Cagliari, Cagliari, 09127, Italy.
³ Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, B3H 4R2, Canada.
⁴ Department of Biomedical Science, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Monserrato, 09042, Italy.
⁵ Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, B3H 2E2, Canada.
⁶ Research and Development, Stremble Ventures, Limassol, 3095, Cyprus.

No abstract available

Keywords: FASTQ; antipsychotics; drug metabolism; microorganism; resistance; schizophrenia.

Publication types